BMYMP vs MRK: Valuation Comparison 2026

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.

Side-by-side fundamentals for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) and Merck & Co., Inc. (MRK) — market cap, PE, PEG and sector. All figures from SEC filings and market data.

Bristol-Myers Squibb Company PFD CONV 2

BMYMP

Healthcare

Full BMYMP valuation →

Merck & Co., Inc.

MRK

Healthcare

Full MRK valuation →
MetricBMYMPMRK
SectorHealthcareHealthcare
IndustryDrug Manufacturers - GeneralBiotechnology
Current Price (Cboe, delayed)$400$148.35
Market Cap$814.59B$366.00B
PE Ratio87.91116.81
PEG Ratio16.515.60
PEG VerdictPotentially OvervaluedPotentially Overvalued
BMYMP fair valueMRK fair valueBMYMP supply chainMRK supply chain

More comparisons

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.